|
A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation |
|
|
|
Title: |
A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation |
Author: |
Zhang, Yanqiong Mao, Xia Chen, Wenjia Guo, Xiaodong Yu, Liangxiang Jiang, Funeng Wang, Xiaoyue Li, Weijie Guo, Qiuyan Li, Taixian Lin, Na |
Appeared in: |
Molecular therapy - nucleic acids |
Paging: |
Volume 19 () nr. C pages 890-904 |
Year: |
2020 |
Contents: |
|
Publisher: |
The Author(s) |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|